Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hill

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World CohortsPeter Martin, Jonathon B Cohen, Michael Wang, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
American Journal of Hematology|April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomesMayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Journal of Biomedical Optics|February 2, 2018
Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trialAnaïs Leproux, Thomas D. O'Sullivan, Albert Cerussi, et al.
Journal of Biomedical Optics|April 7, 2017
Mapping breast cancer blood flow index, composition, and metabolism in a human subject using combined diffuse optical spectroscopic imaging and diffuse correlation spectroscopyHossein S Yazdi, Thomas D O'Sullivan, Anais Leproux, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2025
Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient PerspectiveDeborah M Stephens, Chris Stewart, Liza Avruch, et al.
Plos Biology|June 21, 2019
Challenges and recommendations to improve the installability and archival stability of omics computational toolsSerghei Mangul, Thiago Mosqueiro, Richard J Abdill, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World CohortsPeter Martin, Jonathon B Cohen, Michael Wang, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
American Journal of Hematology|April 5, 2017
The association of histologic grade with acute graft-versus-host disease response and outcomesMayur Narkhede, Lisa Rybicki, Donna Abounader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Journal of Biomedical Optics|February 2, 2018
Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trialAnaïs Leproux, Thomas D. O'Sullivan, Albert Cerussi, et al.
Journal of Biomedical Optics|April 7, 2017
Mapping breast cancer blood flow index, composition, and metabolism in a human subject using combined diffuse optical spectroscopic imaging and diffuse correlation spectroscopyHossein S Yazdi, Thomas D O'Sullivan, Anais Leproux, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2025
Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient PerspectiveDeborah M Stephens, Chris Stewart, Liza Avruch, et al.
Plos Biology|June 21, 2019
Challenges and recommendations to improve the installability and archival stability of omics computational toolsSerghei Mangul, Thiago Mosqueiro, Richard J Abdill, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Pageof 8